feed,title,long_url,short_url
Benzinga,"With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium",https://benzinga.com/general/biotech/22/09/28800063/with-upcoming-pivotal-data-cantor-initiates-coverage-on-actinium,https://bit.ly/3ezExOm
Benzinga,Analysts Give A Thumbs Up To HubSpot As It Takes Moats Over Margins,https://benzinga.com/news/22/09/28798026/analysts-give-a-thumbs-up-to-hubspot-post-boston-event-as-its-moats-outweighed-the-margins,https://bit.ly/3RRwMSr
Benzinga,Exelixis Announces Detailed Results From Late-Stage Cabometyx Combo Trial In Kidney Cancer,https://benzinga.com/general/biotech/22/09/28798935/exelixis-announces-detailed-results-from-late-stage-cabometyx-combo-trial-in-kidney-cancer,https://bit.ly/3qphisV
Benzinga,5 Things You Might Not Know About Los Angeles Rams Quarterback Matthew Stafford,https://benzinga.com/news/22/02/25581473/5-things-you-might-not-know-about-los-angeles-rams-quarterback-matthew-stafford-1,https://bit.ly/3eE2Zyl
Benzinga,Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression,https://benzinga.com/general/biotech/22/09/28799879/tevas-migraine-treatment-effective-in-patients-with-co-morbid-depression,https://bit.ly/3eoKDB1
